-
Vanderbilt CTTC drives record innovation impact in FY25
Vanderbilt CTTC had an exceptional 2025 fiscal year, setting all-time records across multiple metrics while expanding the university's innovation impact. -
Vanderbilt Innovation Ambassadors Program Bridges Gap Between Research and Commercialization
Vanderbilt’s Innovation Ambassadors Program is transforming how academic discoveries translate into societal impact through a peer-to-peer approach that has become a model for universities nationwide. -
Vanderbilt Innovation Catalyst Fund continues advancing research with new review committee
The Vanderbilt Innovation Catalyst Fund bridges the gap between academic research and real-world applications by supporting projects with commercial and societal potential -
Turning Research into Real-World Impact: New Lunch & Learn Series for Faculty
This fall, the Center for Technology Transfer and Commercialization (CTTC) is launching a new Lunch and Learn series designed to help faculty translate their research discoveries into meaningful, real-world applications. Through this series, researchers will gain valuable insights into innovation,… -
Vanderbilt-Discovered Compound Advances to Phase 1 Clinical Trial as a Promising New Treatment for Schizophrenia
Neumora Therapeutics, Inc. has announced the launch of a Phase 1 clinical study evaluating NMRA-861 in healthy adult participants and adults with stable schizophrenia. -
Connecting Research to Real-World Solutions: Karl Zelik's HeroWear Journey
Karl Zelik, a Vanderbilt biomechanical engineer, turned academic research into HeroWear, a company making soft exosuits that reduce back strain and injuries for workers. HeroWear has grown into a global solution that improves safety, comfort, and quality of life for thousands, showing the power of…